JAK2 inhibitor for myelofibrosis: Q&A with Sanofiby
David W.
Sanofi is testing a new drug for myelofibrosis and is presenting details of a phase II study... Clinical Development, Sanofi Oncology to provide further insights regarding myelofibrosis and the company’s...
Genetics Home Reference: primary myelofibrosisby
nih.gov
Reviewed December 2011
What is primary myelofibrosis?
Primary myelofibrosis is a condition... many of the signs and symptoms of primary myelofibrosis.
Initially, most people with primary myelofibrosis...
Drug Offers Relief For Symptoms Of Myelofibrosisby
Ed H.
People with a blood cancer — myelofibrosis — can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients...
Major Gene Mutation Identified in Lymphoma Tumorsby
Cancer.gov
Another JAK2 Inhibitor Shows Promise against Myelofibrosis... with myelofibrosis , a disorder in which the bone marrow is replaced by fibrous tissue. The phase I dose-escalation...
Fw: Hot Topics at TheBody.com's "Ask the Experts" Forumsby
Nelson V.
for myelofibrosis. All these facts put together make these
compounds ameanable for testing to help suppress HIV..., as I said, one
of them is approved: Jakafi is approved by the FDA, which is used for
myelofibrosis. Eventually...
Detailed Information on Myelofibrosisby
JanMyelofibrosis (MF) is one of the myeloproliferative disorders (MPDs). It is also known as agnogenic myeloid metaplasia or meylofibrosis with myeloid metaplasia. Myelofibrosis means fibrosis...